Paper77940
Effect of disodium cromoglycate (Intal) on antigen-induced histamine release from passively sensitized human lung in vitro.
Morr H. Lung, 1978. Cited by 8 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Effect of disodium cromoglycate (Intal) on antigen-induced histamine release from passively sensitized human lung in vitro. Papers, record 77940. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/77940
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effect of disodium cromoglycate (Intal) on antigen-induced histamine release from passively sensitized human lung in vitro.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cromolyn Sodium | Major topic |
| Histamine Release | Major topic |
| Immunization, Passive | Major topic |
| Lung | Major topic |
| Antigen-Antibody Reactions | |
| Asthma | |
| Humans | |
| Immunoglobulin E | |
| In Vitro Techniques | |
| Pollen |
Source PubMed
References16
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6,080,064 | Disodium cromoglycate (FPL 670) ('Intal'): a specific inhibitor of reaginic antibody-antigen mechanisms. | Nature | 1967 | https://conductscience.org/library/papers/6080064 | PubMed |
| 2 | 4,626,442 | A sensitive and specific method for the determination of histomine in human whole blood and plasma. | Hoppe Seylers Z Physiol Chem | 1972 | https://conductscience.org/library/papers/4626442 | PubMed |
| 3 | 60,108 | Mechanism of action of disodium cromoglycate--mast cell calcium ion influx after a histamine-releasing stimulus. | Biochem Pharmacol | 1976 | https://conductscience.org/library/papers/60108 | PubMed |
| 4 | 4,168,447 | Release of histamine and slow reacting substance with mast cell changes after challenge of human lung sensitized passively with reagin in vitro. | Nature | 1967 | https://conductscience.org/library/papers/4168447 | PubMed |
| 5 | 4,360,669 | The anti-anaphylactic actions of disodium cromoglycate, theophylline, isoprenaline and prostaglandins. | Int Arch Allergy Appl Immunol | 1974 | https://conductscience.org/library/papers/4360669 | PubMed |
| 6 | 4,189,435 | Disodium cromoglycate. Activity in three in vitro models of the immediate hypersensitivity reaction in lung. | Int Arch Allergy Appl Immunol | 1970 | https://conductscience.org/library/papers/4189435 | PubMed |
| 7 | 4,105,807 | Immunological release of histamine and slow-reacting substance of anaphylaxis from human lung. I. Modulation by agents influencing cellular levels of cyclic 3',5'-adenosine monophosphate. | J Exp Med | 1971 | https://conductscience.org/library/papers/4105807 | PubMed |
| 8 | 6,057,948 | Antigen induced release of histamine and SRS-A from human lung passively sensitized with reaginic serum. | Nature | 1967 | https://conductscience.org/library/papers/6057948 | PubMed |
| 10 | 4,363,217 | Inhibition of cAMP phosphodiesterase by disodium cromoglycate. | Biochem Pharmacol | 1974 | https://conductscience.org/library/papers/4363217 | PubMed |
| 12 | 46,885 | Prevention of calcium ionophore-induced release of histamine in rat mast cells by disodium cromoglycate. | J Immunol | 1975 | https://conductscience.org/library/papers/46885 | PubMed |
| 13 | 4,189,806 | Inhibition of allergic reactions in man and other species by cromoglycate. | Int Arch Allergy Appl Immunol | 1970 | https://conductscience.org/library/papers/4189806 | PubMed |
| 14 | 14,446,178 | A method for the fluorometric assay of histamine in tissues. | J Pharmacol Exp Ther | 1959 | https://conductscience.org/library/papers/14446178 | PubMed |
| 15 | 49,315 | The effect of glucocorticoids and catecholamines on cyclic AMP and allergic histamine release in guinea pig lung. | Int Arch Allergy Appl Immunol | 1975 | https://conductscience.org/library/papers/49315 | PubMed |
| 16 | 50,289 | Drug inhibition of anaphylactic histamine release from peritoneal cells of rats infected with Toxocara canis. | Int Arch Allergy Appl Immunol | 1975 | https://conductscience.org/library/papers/50289 | PubMed |
| 17 | 4,101,095 | Mode of action of disodium cromoglycate, studies on immediate type hypersensitivity reactions using 'double sensitization' with two antigenically distinct rat reagins. | Clin Exp Immunol | 1970 | https://conductscience.org/library/papers/4101095 | PubMed |
| 18 | 50,438 | Effect of cromolyn sodium and deuterium oxide on anaphylactic histamine release from rat peritoneal mast cells in vitro. | J Pharmacol Exp Ther | 1975 | https://conductscience.org/library/papers/50438 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6,189,542 | The characteristics of inhibition of histamine release from human lung fragments by sodium cromoglycate, salbutamol and chlorpromazine. | Br J Pharmacol | 1983 | https://conductscience.org/library/papers/6189542 | PubMed |
| 115,530 | A comparison of the anti-anaphylactic activities of salbutamol and disodium cromoglycate in the rat, the rat mast cell and in human lung tissue. | Br J Pharmacol | 1979 | https://conductscience.org/library/papers/115530 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/77940
GET https://conductscience.org/api/papers/v1/77940/authors